Thermodynamics of Coronary Blood Flow During Targeted Temperature Management Post-Cardiac Arrest

Targeted Temperature Management (TTM) at 32°C to 34°C represents the standard of care for comatose survivors of out-of-hospital cardiac arrest. While the neuroprotective mechanisms of hypothermia are well-characterized through suppression of cerebral metabolic rate and attenuation of excitotoxicity, the direct physicochemical effects on coronary hemodynamics remain incompletely understood by practicing clinicians. This comprehensive analysis examines the application of the Hagen-Poiseuille equation to coronary blood flow during therapeutic hypothermia, incorporating the temperature-dependent behavior of blood viscosity as described by the Andrade-Euler relationship. Through rigorous mathematical modeling and detailed case analysis of patients from the International Cardiac Arrest Registry (INTCAR), this article demonstrates that the 20% to 28% increase in blood viscosity observed during cooling from 37°C to 33°C produces a mathematically predictable 17% to 22% reduction in coronary flow reserve when all other physiological parameters remain constant. This fundamental physical constraint creates a supply-demand mismatch in the post-ischemic myocardium that, if unrecognized, contributes to hemodynamic instability and myocardial stunning. The analysis further presents quantitative hemodynamic data from 147 patients enrolled in the TTM-2 trial substudy, demonstrating the temporal relationship between core temperature reduction and changes in coronary perfusion pressure, cardiac index, and mixed venous oxygen saturation. Mathematical derivations include the application of the Navier-Stokes equations for incompressible fluids under laminar flow conditions, the Casson model for non-Newtonian blood behavior at variable shear rates, and the Arrhenius equation for temperature-dependent viscosity changes. Clinical correlations utilize thermodilution-derived coronary flow measurements obtained during the cooling, maintenance, and rewarming phases of TTM. This integrated approach provides clinicians with a quantitative framework for anticipating and managing the hemodynamic consequences of therapeutic hypothermia, potentially improving myocardial recovery and neurological outcomes in post-cardiac arrest patients.